Related Experiment Video
Updated: Jul 16, 2026
07:22
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Biotechnological challenges of phage therapy
Mikael Skurnik1, Maria Pajunen, Saija Kiljunen
1Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland. mikael.skurnik@helsinki.fi
Biotechnology Letters
|March 17, 2007
Summary
Launching a profitable phage therapeutic requires overcoming challenges like intellectual property and safety. A successful product involves purified bacteriophages, optimized administration, and robust efficacy and safety data.
Area of Science:
- Microbiology
- Biotechnology
- Pharmaceutical Science
Background:
- Bacteriophage therapy presents a promising alternative to antibiotics.
- Significant hurdles exist in translating phage research into marketable products.
Purpose of the Study:
- To outline the critical factors for developing a successful and profitable phage therapeutic product.
- To identify key considerations for intellectual property, safety, and product characterization.
Main Methods:
- Review of existing challenges in phage therapeutic development.
- Analysis of requirements for a marketable phage product.
Main Results:
- Key challenges include intellectual property, safety, reproducibility, stability, and robustness.
- A marketable product necessitates highly purified bacteriophages, optimized administration, and rigorous efficacy/safety studies.
Conclusions:
- Addressing these challenges is crucial for the successful commercialization of phage therapeutics.
- A comprehensive approach encompassing product characterization, administration, and validation is essential.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:26DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Bacteriophages of the Human Virome
Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
01:16Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...